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Abstract
There is growing evidence of the public health and community harms associated with crack cocaine
smoking, particularly the risk of blood-borne transmission through non-parenteral routes. In
response, community advocates and policy makers in Vancouver, Canada are calling for an
exemption from Health Canada to pilot a medically supervised safer smoking facility (SSF) for non-
injection drug users (NIDU). Current reluctance on the part of health authorities is likely due to
the lack of existing evidence surrounding the extent of related harm and potential uptake of such
a facility among NIDUs in this setting. In November 2004, a feasibility study was conducted among
437 crack cocaine smokers. Univariate analyses were conducted to determine associations with
willingness to use a SSF and logistic regression was used to adjust for potentially confounding
variables (p < 0.05). Variables found to be independently associated with willingness to use a SSF
included recent injection drug use (OR = 1.72, 95% CI: 1.09–2.70), having equipment confiscated
or broken by police (OR = 1.96, 95% CI: 1.24–2.85), crack bingeing (OR = 2.16, 95% CI: 1.39–3.12),
smoking crack in public places (OR = 2.48, 95% CI: 1.65–3.27), borrowing crack pipes (OR = 2.50,
95% CI: 1.86–3.40), and burns/ inhaled brillo due to rushing smoke in public places (OR = 4.37, 95%
CI: 2.71–8.64). The results suggest a strong potential for a SSF to reduce the health related harms
and address concerns of public order and open drug use among crack cocaine smokers should a
facility be implemented in this setting.
Introduction
Vancouver's Downtown Eastside (DTES) has been the site
of an explosive HIV and HCV epidemic associated with a
large open illicit drug use scene[1,2]. The health related
concerns of injection drug use, particularly blood borne
transmission, have been documented extensively [3,4]. In
response to these health related risks and concerns of pub-
lic order in this community, several harm reduction initi-
atives have been implemented recently and in September
2003 Vancouver received an exemption from Health Can-
ada to pilot the first supervised injection facility in North
America [5].
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To date, the scientific evaluation of the supervised injec-
tion facility has documented several successes including
high uptake of the facility, improved public order [6], and
a positive impact in reducing syringe sharing locally [7].
However Vancouver is still contending with a open drug
scene and issues of public order, particularly among non-
injection drug using (NIDU) crack cocaine smokers and
crystal methamphetamine users [8]. Growing evidence
has highlighted the health related harms of crack cocaine
use, including the risk of non parental transmission of
HCV, through the sharing of non-injection drug use para-
phernalia [9-11], and risky sexual behaviours[12,13].
Crack smokers are known to have a high prevalence of
oral lesions, including burns, blisters, and sores, on lips
and mouth that may facilitate the oral transmission of
blood-borne infections [14]. In addition, crack cocaine
smokers have been shown to be at increased likelihood of
engaging in high risk sexual and drug related behaviours
associated with both HCV and HIV infections [12].
In Europe, several safer smoking facilities (SSF) for non-
injection drug users have been opened in addition to
supervised injection facilities [15], and yet in North Amer-
ica, the extent and potential uptake of such a facility
among NIDUs have not been characterized. Currently
supervised drug consumption facilities are operating in 36
cities across four European countries [15]. The existing lit-
erature indicates that the ideal drug consumption room is
made up of three sections: a clinical area for injecting, a
well-ventilated area for free-basing or chasing, and an
adjacent common room where no drug use is allowed
[16]. Of the 22 drug consumption facilities in the Nether-
lands, all 22 facilities include spaces for injectors and
inhalation areas for crack and heroin smokers [15]. The
primary mode of drug consumption in Dutch consump-
tion rooms is smoking or chasing[16], and increasingly
present in both German and Swiss facilities [17]. Of the
12 drug consumption facilities in Switzerland, 8 provide
spaces for both injection and inhalation. The objectives of
a safer smoking facilities are similar to those of injection
facilities including a safe environment that enables low-
risk, more hygienic drug consumption, reducing the
health related risks of drug use and sharing of smoking
paraphernalia, minimising the open drug use scene and
associated public nuisance, and establishing contact with
hard-to-reach drug user populations [18-21]. Through
engaging high-risk populations that would otherwise
remain outside of conventional medical care, SSF aim to
increase potential uptake of health services, drug treat-
ment and addiction services, referral to housing and social
supports, and ultimately stabilize and promote client
health [15]. Similar to safe injection facilities, SSF provide
sterile drug use equipment, a clean and safe environment
to use drugs, and education describing the risks of crack
smoking and safer ways to smoke. As well, a key opportu-
nity exists at a SSF to delay or prevent the transition from
inhaling to injecting drugs [22]. Previous studies have
shown that 85% of IDUs engage in illicit non-injection
drug use prior to initiating injection drug use [23], and
evidence suggests that interventions need to target crack
smokers to prevent transition to injecting [24].
Currently advocates and policy makers in Vancouver,
Canada are calling for a medically supervised safer smok-
ing facility to smoke pre-obtained non-injection drugs,
particularly crack cocaine, and consideration is being
given to applying for a federally-administered exemption
from Health Canada (under exemption 56) to pilot a safe
inhalation room [25,26]. Although evidence of the extent
of the health related risks of crack cocaine smoking is
growing, the reluctance on the part of health authorities is
likely due to the lack of existing evidence of crack use
harms and potential uptake of a SSF by crack cocaine
smokers in this setting. As such, a partnership between the
Rock Users' Group of VANDU and CHASE, a community-
based research project, undertook an assessment of the
willingness to use a safer smoking facility should one be
made available.
Methods
Vancouver Area Network of Drug Users (VANDU)
The Vancouver Area Network of Drug Users (VANDU) is a
drug user organization that formed in 1997 in response to
a growing HIV epidemic and health emergency in the
Downtown Eastside of Vancouver associated with illicit
drug use, and perceived government inaction. The mis-
sion of VANDU is "to improve the lives of people who use
illicit drugs through user-based peer support and educa-
tion"[27]. Today, the organization has grown to include
approximately 1500 members and is well known interna-
tionally as one of the most organized drug user associa-
tions in the world. In addition to ongoing political
activism and advocacy, VANDU has expanded over the
years to include public education, and peer support and
care programs for methadone users and Hepatitis C posi-
tive individuals. As well the organisation provides a
syringe exchange and recovery program, alley patrol, and
street and hotel-based programs.
The Rock Users' Group (RUG) was formed through
VANDU in response to a growing need to address the
health needs of crack cocaine smokers. The RUG group
meets weekly to educate members on the related concerns
of crack cocaine use and discuss ways to expand harm
reduction initiatives to include crack smokers. Through
private donations, RUG has recently begun distributing
safer smoking kits to users in the community at a cost of
Can$1, including a mouthpiece, durex pipe, brass screens,
lubricant, and condoms.Harm Reduction Journal 2006, 3:1 http://www.harmreductionjournal.com/content/3/1/1
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The Community Health and Safety Evaluation (CHASE) 
project
The Community Health and Safety Evaluation (CHASE)
Project is a prospective open cohort that was established
to evaluate the impacts of recently implemented health
initiatives on residents of the DTES; to identify priority
health issues; shortfalls; and populations at greatest risk.
All community residents are eligible to participate, and
are enrolled through various recruitment strategies
including community-based organizations, several store-
front locations and door-to-door initiatives in a single
room occupancy hotel (SRO) and subsidised housing
buildings. The goal is to enrol a large representative sam-
ple of people residing in and having access to services in
the DTES community. A short baseline questionnaire is
administered by a trained peer interviewer, and elicits
questions related to sociodemographic characteristics,
health status, service utilization, barriers to healthcare
access, and patterns of illicit drug use. In addition, permis-
sion is requested to link personal identifiers with a
number of health related databases in the province. Par-
ticipants are followed prospectively through these data
linkages on a bi-annual bases. Upon completion of the
survey, study participants receive an honorarium of $10 as
compensation for their time. University of British Colum-
bia / Providence Health Care Research Ethics Board pro-
vided ethical approval for this study.
Assessment of the health related harms of crack smoking
Through a community-based partnership between the
Rock Users' Group (RUG) of Vancouver Area Network of
Drug Users (VANDU) and the Community Health and
Safety Evaluation (CHASE) Project of the BC Centre for
Excellence in HIV/AIDS, the following assessment of
health related harms of crack cocaine use was conducted
in November of 2004. A total of 437 crack cocaine smok-
ers participated in peer-administered interviews. To be eli-
gible, individuals had to be current crack cocaine smokers
(i.e., defined as having smoked crack cocaine in the previ-
ous month at the time of interview). Participants were
recruited through targeted recruitment strategy that
included allocation of referral cards at staggered times and
locations over a three-week period. Referral cards were
handed-out by CHASE peers through street recruitment
and VANDU members on alley patrol and outreach with
active crack smokers, as well as through community-based
organisations and service providers. Questionnaires were
conducted at various storefront locations, and included
women's only days to ensure inclusion of multi-risk
women. Although participants were asked about former
and current injection drug use practices, a history of injec-
tion drug use was not considered an eligibility criteria and
thus both IDU and NIDU crack smokers were eligible to
participate.
Socio-demographic variables that were considered in this
analysis included gender, age, ethnicity, housing status,
education level, health status, health and addiction serv-
ice uptake, recent incarceration, and drug use patterns. For
the purpose of this analysis, unstable housing was defined
as living arrangements that included SRO hotels, transi-
tional housing, and no fixed address/ homelessness. Drug
use behaviours included: frequency of cocaine injection,
heroin injection, crystal methamphetamine injection, and
crack cocaine smoking. As previously [28], "any drug use"
was defined as any illicit drug use in the last six months at
the time of interview and "frequent drug use" was defined
as daily, or most days. Risky drug behaviours included
crack bingeing, borrowing crack pipes, smoking in a
group of unknown people (such as crack houses, or
alleys), and buying used pipes off the street. Public drug
use variables included frequency of smoking crack in pub-
lic places (such as streets, alleys, and parks), having felt in
danger when smoking in public places, rushing smoke
due to police presence, inhaling brillo / burns due to rush-
ing, and having equipment confiscated or broken by
police (without being arrested). Sex work variables
included ever having exchanged sex for money or drugs,
and having exchanged sex for money or drugs while using
crack in the last six months.
Descriptive and univariate analysis were used to deter-
mine bivariate associations between willingness to use a
SSF and sociodemographic characteristics, selected drug
use patterns, crack use behaviours and related risks. Mean
averages were used to describe normally distributed varia-
bles, and median averages were used to describe skewed
variables. Categorical and explanatory variables were ana-
lyzed using Pearson X2, normally distributed continuous
variables were analyzed using t-tests for independent var-
iables, and skewed continuous variables were analyzed
using Mann-Whitney U tests. In order to identify factors
independently associated with willingness to use a SSF, a
logistic regression was performed. Variables found to be
associated with willingness to use a SSF at the univariate
level (p < 0.05) were entered into the logistic model. All
reported p-values are two-sided.
Results
A total of 437 participants were recruited over a three-
week period in November 2004, and thus were eligible for
the present analysis. Of the total, 289 (66%) were male
and 145 (33%) were female. The median age was 41 years
(interquartile range [IQR] = 35 – 45). One-hundred and
eighty-four (42%) individuals self identified as Aborigi-
nal, and 335 (77%) were living in unstable housing. Two-
hundred and forty-six (56%) reported a history of injec-
tion drug use (either former of current IDUs), while 191
(44%) were NIDU crack smokers with no history of injec-
tion drug use.Harm Reduction Journal 2006, 3:1 http://www.harmreductionjournal.com/content/3/1/1
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Of the 437 participants, 303 (69%) expressed a willing-
ness to use a medically supervised safer smoking facility
(SSF) if one was made available. The univariate analyses
of associations between willingness to use a safer smoking
facility and sociodemographic characteristics and selected
drug use patterns are shown in Table 1. As indicated, will-
ing to use a SSF was positively associated with homeless-
ness (OR = 2.61, 95% CI: 1.19–5.71), having slept
outdoors in the last six months (OR = 1.91, 95% CI: 1.22–
2.98), exchanging sex for money or drugs while using
crack (OR = 1.76, 95% CI: 1.00–3.24), recent IDU (OR =
1.71, 95% CI = 1.27–2.31), injecting with others (OR =
2.15, 95% CI: 1.39–3.32), and injection binge drug use
(OR = 2.10, 95% CI: 1.30–3.38).
The univariate analyses of associations between willing-
ness to use a SSF and crack use behaviours and related
risks are shown in Table 2. As indicated, willingness to use
a SSF was positively associated with daily crack cocaine
use (OR = 1.31, 95% CI: 1.00–1.73), crack bingeing (OR
= 2.25, 95% CI: 1.46–3.46), smoking crack in public
places (such as, streets, alleys, parks) (OR = 2.59, 95% CI:
1.79–3.12), smoking crack in a group of unknown people
(such as crack houses, or alleys) (OR = 2.20, 95% CI =
1.73–5.36), borrowing crack pipes (OR = 2.78, 95% CI:
2.17–3.71), buying used pipes off the street (OR = 2.34,
95% CI: 1.14–4.77), feeling in danger when smoking
crack in public places (OR = 2.37, 95% CI: 1.53–3.75),
rushed smoking due to police presence (OR = 3.89, 95%
CI: 2.44–6.22), inhaling brillo/ burns due to rushing
smoke (OR = 4.45, 95% CI:2.55–7.76), and having equip-
ment confiscated or broken by police (without being
arrested) (OR = 2.26, 95% CI: 1.48–3.46).
Results of the multivariate logistic regression analysis of
factors independently associated with willingness to use a
SSF are presented in Table 3. Variables found to be inde-
pendently associated with willingness to use a SSF
included recent injection drug use (OR = 1.72, 95% CI:
1.09–2.70), having equipment confiscated or broken by
police (OR = 1.96, 95% CI: 1.24–2.85), crack bingeing
(OR = 2.16, 95% CI: 1.39–3.12), smoking crack in public
places (OR = 2.48, 95% CI: 1.65–3.27), borrowing crack
pipes (OR = 2.50, 95% CI: 1.86–3.40), and inhaled brillo/
burns due to rushing smoke in public places (OR = 4.37,
95% CI: 2.71–8.64).
Table 1: Univariate associations between sociodemographic characteristics, selected drug use behaviours and willingness to use a safer 
smoking facility (SSF)
Willingness to Use a Safer Smoking Facility
Characteristic Yes No OR p-value
n(%) n(%) (95% CI)
Age
Median [IQ range] 40 (35–46) 41 (34–45) 0.729
Gender
Male 199 (67) 90 (68) 0.90 (0.58–1.39) 0.642
Female 103 (34) 42 (32)
Ethnicity
Aboriginal 136 (45) 48 (36) 1.46 (1.00–2.22) 0.077
Non-Aboriginal 167 (55) 86 (64)
Homeless
Yes vs. No 43 (14) 8 (6) 2.61 (1.19–5.71) 0.014
Slept outdoors
Yes vs. No 122 (40) 35 (26) 1.91 (1.22–2.98) 0.004
HIV positive
Yes vs. No 81 (27) 30 (22) 1.18 (0.84–1.67) 0.336
HCV positive
Yes vs. No 210 (69) 86 (64) 1.17 (0.90–1.57) 0.290
Exchanged sex for drugs or money
Yes vs. No 107 (35) 38 (28) 1.26 (0.91–1.73) 0.154
Exchanged sex for drugs or money while using crack (last 6 months)
Yes vs. No 55 (18) 15 (11) 1.76 (1.00–3.24) 0.047
Current IDU
Yes vs. No 163 (54) 47 (35) 1.71 (1.27–2.31) <0.001
Inject with others
Yes vs. No 142 (47) 39 (29) 2.15 (1.39–3.32) 0.001
Injection bingeing
Yes vs. No 108 (36) 28 (21) 2.10 (1.30–3.38) 0.002Harm Reduction Journal 2006, 3:1 http://www.harmreductionjournal.com/content/3/1/1
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Interpretation
Of a total of 437 crack cocaine smokers, 303 (69%)
reported a willingness to use a safer smoking site (SSS)
should one be made available. A willingness to use a SSF
was associated with recent injection drug use, having
equipment confiscated or broken by police, crack binge
use, smoking crack in public places, borrowing crack
pipes, and burns/ inhaled brillo due to rushed smoking.
The association between crack bingeing and willingness to
use a SSF shows a potential for such a facility to intervene
in risky drug use behaviours through increased contact
and referral with primary care, education and addiction
services [29]. Drug bingeing has been previously identi-
fied as a high-risk behaviour associated with an elevated
risk of HIV seroconversion [30,31]. Intensive crack use has
also been associated with increased sexual risk taking,
including exchanging sex for drugs or money, multiple sex
partners and unprotected sexual encounters[12,13].
In this context, the observed association between borrow-
ing crack pipes and willingness to use a SSF is particularly
noteworthy given the increasing evidence of blood borne
transmission through the sharing of non-injection drug
use implements and the potential of a SSF to reach this
high-risk group. Oral sores, cuts, and burns are common
among crack cocaine smokers and have been shown to
facilitate HCV transmission, as well as increased potential
risk for HIV transmission, through the sharing of contam-
inated equipment, such as crack pipes [9,10,32]. Given
the ability of Hepatitis C virus to maintain its infectivity in
the environment, the risk of sharing of drug use equip-
ment is particularly concerning [11]. Increasing evidence
highlights a higher rate of HCV infection among crack
cocaine and heroin smokers reporting no history of injec-
tion drug use when compared to the general popula-
tion[10]. A previous study among female drug users with
no history of injection use, found that the sharing of both
oral and intranasal non-injection drug use implements
was a significant and independent predictor of HCV infec-
tion after accounting for other known transmission routes
[9]. Given the high prevalence (51%) of individuals hav-
ing smoked in a group of unknown people (such as crack
houses or alleys) in the last six months, as well as the high
number of injection drug using crack smokers in this
study, the potential for sharing of crack pipes between
IDU and NIDU smokers highlights an increased likeli-
hood for infectious disease transmission. In light of these
findings, and the previously observed impacts of drug
consumption facilities on sharing of drug use equipment
Table 2: Univariate associations between crack use behaviours and related risks, and willingness to use a safe smoking facility (SSF)
Willingness to Use a Safer Smoking Facility
Characteristic Yes No OR p-value
n(%) n(%) (95% CI)
Crack use history
≥ 5 years 174 (57) 70 (56) 0.94 (0.62–1.44) 0.786
≥ 10 years 84 (28) 31 (25) 1.11 (0.90–1.57) 0.535
Daily crack cocaine use
Yes vs. No 183 (60) 68 (51) 1.31 (1.00–1.73) 0.060
Crack bingeing
Yes vs. No 228 (75) 77 (58) 2.25 (1.46–3.46) <0.001
Smoke crack in public places (ie, streets, alleys, parks)
Yes vs. No 170 (56) 53 (40) 2.59 (1.79–3.12) 0.001
Smoke in a group of unknown people (ie, crack houses, alleys)
Yes vs. No 157 (52) 44 (33) 2.20 (1.44–3.36) <0.001
Borrowed crack pipes
Yes vs. No 212 (70) 76 (57) 2.78 (2.17–3.71) 0.007
Buy used pipes off the street
Yes vs. No 48 (16) 10 (8) 2.34 (1.14–4.77) 0.017
Cocaine-induced psychosis/paranoia
Yes vs. No 116 (38) 45 (33) 1.15 (0.85–1.56) 0.347
Felt in danger when smoking in public
Yes vs. No 139 (46) 35 (26) 2.40 (1.53–3.75) <0.001
Rushed smoking due to police presence
Yes vs. No 157 (52) 29 (22) 3.89 (2.44–6.22) <0.001
Inhaled brillo/burns due to rushing smoke
Yes vs. No 121 (40) 12 (9) 4.45 (2.55–7.76) <0.001
Equipment confiscated or broken by police (without being arrested)
Yes vs. No 159 (53) 44 (33) 2.26 (1.48–3.46) <0.001Harm Reduction Journal 2006, 3:1 http://www.harmreductionjournal.com/content/3/1/1
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[7], SSFs may have the potential to reduce harms associ-
ated with crack pipe sharing in this setting.
The observed association between willingness to use a SSF
and recent injection use is also particularly relevant, given
that this feasibility study was conducted a year following
the implementation of the SIF in this community. As
mentioned above, the SIF has had positive impacts by
improving public order[6], minimising the number of
discarded needles in public places, and reducing local
syringe sharing [7]. However, the open drug use scene in
alleys, doorways and parks persists[8], and is likely reflec-
tive of the high rates of NIDU, particularly crack smokers,
in this community. As well, given the high percentage of
dual users in this study, the implementation of a SSF may
help to engage IDU crack smokers who continue to con-
sume drugs in public places. In addition, SSFs also have
the opportunity to delay or prevent the transition from
inhaling to injecting drugs though prevention-transition
programs [22]. Recent studies have suggested that the
infection risk hierarchy should be updated to include the
public health importance of preventing transition to
injection drug use[29], and approximately 85% of IDUs
report non-injection drug use prior to initiation into injec-
tion use[23].
Given the objective of drug consumption rooms to reduce
public nuisance and a visible drug scene, the observed
association between public crack use and increased will-
ingness to use a SSF is also noteworthy. Although there is
currently limited information available exclusively on
SSFs, preliminary findings in Switzerland show an
increase in public order and increased contact between
NIDUs and health and social services[17]. As well, several
studies of drug consumption rooms in Europe have high-
lighted the benefits of both injection and inhalation areas
to increase public order, engage high-risk groups, and
reduce visible drug scenes [18-21].
Within the context of public drug use, the associations
between willingness to use a SSF, and burns or/ inhaled
brillo due to rushing smoke and having equipment con-
fiscated or broken by police, highlight a strong potential
to reduce the community harms of public crack use and
concerns of public order. Common modes of crack
cocaine smoking such as metal pipes are known to cause
frequent burns and blisters through excessive heat, while
glass and durex pipes frequently splinter causing a
smoker's lips to cut [14,33]. In addition, brillo or brass
screens commonly used as filters in the pipe stem may
break up and be inhaled by the user when the process is
rushed. The epidemic of crack cocaine has been associated
with heightened violence and crime, as well as exploita-
tion of users, particularly women [12]. In Vancouver,
speculations suggest widespread human rights violations
on public drug users as part of the police crack down on
open drug use scene and concerns of public order [34].
Given that a key objective of drug consumption rooms is
to provide a safe place to use pre-obtained illicit drugs and
hygienic drug use equipment, these findings highlight a
potential to move crack smokers out of alleys and streets,
minimize risky crack use, and related harms of rushing in
public places should a SSF be implemented in this setting.
Similar to safe injection facilities[35], SSF would also pro-
vide a key opportunity to couple enforcement and public
health efforts as police officers could direct NIDUs on the
street to a SSF [22].
Several limitations should be considered. First, this study
relied on self-reported information and thus is subject to
socially desirable reporting. However previous studies
have reported the validity of self-reported information
among drug user populations[36]. Second, this study ask
participants about the willingness to use a safer smoking
facility that does not currently exist and thus participants
may have been unsure about the potential use of such a
facility. However given that a supervised injection facility
has recently been implemented in this setting, and the
high rates of injection use among crack cocaine smokers,
it is likely that individuals would have been familiar with
the concept of a drug consumption site. In addition, sim-
ilar feasibility studies were conducted prior to the opening
of the SIF and were highly predictive of the uptake
observed following the opening of the SIF[37,38].
The high reported rate of willingness to use a safer smok-
ing facility (SSF) in this study highlights an important
opportunity to connect with a known high-risk drug user
Table 3: Logistic Regression Model of Factors Associated with Willingness to Use a Safer Smoking Facility
Characteristic AOR 95% CI p-value
(95% CI)
Current IDU 1.72 1.09–2.70 0.019
Equipment confiscated or broken by police 1.96 1.24–2.85 0.003
Crack bingeing 2.16 1.39–3.12 0.014
Smoking crack in public places 2.48 1.65–3.27 0.002
Borrowing crack pipes 2.50 1.86–3.40 0.006
Inhaled brillo/burns due to rushing smoke 4.37 2.71–8.64 <0.001Harm Reduction Journal 2006, 3:1 http://www.harmreductionjournal.com/content/3/1/1
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population. Given the observed associations between
willingness to use a SSF and public drug use and related
harms, borrowing of crack pipes, and other risky drug use
behaviours, this study identifies a strong potential to
reduce community health risks, including infectious dis-
ease transmission, and address issues of open drug use
and concerns of public order, if a facility was imple-
mented in this setting.
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